Cargando…
Structure Based Antibody-Like Peptidomimetics
Biologics such as monoclonal antibodies (mAb) and soluble receptors represent new classes of therapeutic agents for treatment of several diseases. High affinity and high specificity biologics can be utilized for variety of clinical purposes. Monoclonal antibodies have been used as diagnostic agents...
Autores principales: | Murali, Ramachandran, Greene, Mark I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763629/ https://www.ncbi.nlm.nih.gov/pubmed/24288089 http://dx.doi.org/10.3390/ph5020209 |
Ejemplares similares
-
Peptidomimetic-based antibody surrogate for HER2
por: Zheng, Mengmeng, et al.
Publicado: (2021) -
Short Cationic Peptidomimetic Antimicrobials
por: Kuppusamy, Rajesh, et al.
Publicado: (2019) -
Peptidomimetics Therapeutics for Retinal Disease
por: Parsons, Dylan E., et al.
Publicado: (2021) -
Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022) -
Using the ribosome to synthesize peptidomimetics
por: Freidinger, Roger M
Publicado: (2009)